Singapore Paincare Holdings (FRQ) Fair Value & Analysis
Healthcare · SG · Market cap 10.3M SGD
Fair value as of: Jul 4, 2026
From 13 valuation models · updated today
Share price −21.1% over the past month.
Price vs Fair Value (12 months)
12‑month range 0.0600 SGD – 0.1600 SGD · fair‑value band 0.0556 SGD – 0.0823 SGD · the 0.0600 SGD price screens below the 0.0715 SGD fair value. As of Jul 4, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Singapore Paincare Holdings (FRQ) currently trades at 0.0600 SGD, while our model-based Fair Value estimate is 0.0715 SGD — implying the stock looks roughly 19.1% undervalued today. We read business quality at 52/100 (solid quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
Over the trailing twelve months, Singapore Paincare Holdings generated revenue of 26.6M SGD at a net margin of -18.4%. Revenue declined 2.9% year over year. It earns a return on equity of -21.8%. Fundamentals as of Jul 4, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 4, 2026. TTM = trailing twelve months.
About the company
Singapore Paincare Holdings Limited, an investment holding company, operates medical clinics in Singapore. It operates general practitioner clinics, specialist clinics, traditional Chinese medicine centers, and physiotherapy centers for pain screening and treatments, cancer pain therapy, pharmacotherapy, and cognitive behavioral therapy. The company was founded in 2007 and is based in Singapore.
Revenue & earnings trend
FY2020 – FY2025 · reported fiscal years
Singapore Paincare Holdings reported revenue of 26.9M SGD in FY2024 versus 9.6M SGD in FY2020, a compound +29.2%/yr. Reported net income was −4.0M SGD in FY2025.
Is FRQ fairly valued? → Check now
Similar stocks
6 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jul 4, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc H1CA34 | R$96.00 | R$25.67 | -73% |
| Fresenius SE FSNUY | $11.30 | $8.61 | -24% |
| Q0F Q0F | 2.76 SGD | 1.28 SGD | -54% |
| 5225 5225 | 8.67 MYR | 3.08 MYR | -64% |
| IHHHF IHHHF | $1.71 | $0.7400 | -57% |
| Rede D'Or São Luiz S.A RDOR3 | R$32.76 | R$30.33 | -7% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Singapore Paincare Holdings (FRQ) undervalued?
What is the fair value of FRQ?
What is the quality score of FRQ?
What is the revenue of Singapore Paincare Holdings (FRQ)?
What is the net profit margin of FRQ?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.